Lysozyme (Muramidase), Serum
Lysozyme, also known as muramidase, is part of the innate immune system secreted by macrophages and polymorphonuclear neutrophils (PMNs). The enzyme has protective function and it is also present in tears, saliva, human milk and mucus. Its main protective function is to damage bacterial cell walls.
The presence of lysozyme enzyme in plasma comes mainly from the degradation of granulocytes and monocytes which is the result of inflammation and increased cell proliferation. Increased levels of lysozyme are seen in infections and inflammation, as well as in malignancies such as chronic granulocytic or monocytic leukemias, myeloproliferative disorders and malignant histiocytosis. Conversely, patients with lymphocytic leukemia may have depressed plasma lysozyme levels. Elevated levels of lysozyme are also seen in certain renal diseases including rejection of transplanted kidneys. Also, elevated levels of this enzyme are seen in Crohn’s disease and sarcoidosis, but is less specific.
Reduced lysozyme levels have been associated with Bronchopulmonary Dysplasia (BPD) and Hyaline Membrane Disease (HMD). Patients who have BPD may be more susceptible to damage from inflammatory cell products because they inhibit the antiprotease activity. The measurements of lysozyme level might reveal a recognizable profile of tracheal aspirate composition that can be used to predict the risk for the development of BPD.
Along with lysozyme enzyme, the use of secretory IgA and lactoferrin would lead to better diagnosis, disease management and prognosis since they are also secreted in a similar way to lysozyme.
- As an aid in diagnosis of inflammatory process in Bronchopulmonary Dysplasia and Hyaline Membrane Disease
- Risk assessment for the development of Bronchopulmonary Dysplasia
- As an aid in diagnosis of chronic granulocytic or monocytic leukemias
- As an aid in diagnosis of Sarcoidosis
- Disease management and monitoring
Increased in:
- Acute myelocytic leukemia with monocytic differentiation
- Chronic granulocytic leukemia
- Tuberculosis
- Sarcoidosis
- Renal diseases
- Crohn’s disease
Decreased in:
- Bronchopulmonary dysplasia
- Hyaline membrane disease
Adult (Serum): 6.9-12.7 mg/L
Children (Serum): 8.5-13.1 mg/L
Newborn (Serum): 8.9-12.3 mg/L
Umbilical blood (Serum): 6-11 mg/L
Cerebrospinal Fluid (CSF): up to1.8 mg/L
Amniotic fluid: 6.3-12.3 mg/L
Transudates: up to 41.0 mg/L
Pus: 110-190 mg/L
Primarily from pulmonary fluid, tracheal aspiration and serum of adults and children can be used. Exudates can be used to detect the inflammatory process secreting lysozyme enzyme in respective tissues.
Stability
- Room temp: 8 hours
- Refrigerated: 1 week
- Frozen: 1 month
- J Pediatr. 1992 Aug;121(2):262-70. [PMID: 1640295]
- Clin Biochem. 1989 Oct;22(5):349-55. [PMID: 2680166]
- Biochem Biophys Res Commun. 1988 Jan 29;150(2):794-801. [PMID: 2829884]
- Clin Chim Acta. 1984 Sep 15;142(1):21-30. [PMID: 6383662]
- Clin Chim Acta. 1974 Dec 17;57(3):205-9. [PMID: 4434640]
- J Exp Med. 1966 Nov 1;124(5):921-52. [PMID: 5224561]